MultiPark researcher behind Alzheimer’s Association Recommendations about use of Alzheimer’s “Blood Tests”

12 September, 2022

Alzheimer’s Association recently released recommendations about using blood-based biomarkers to detect Alzheimer’s disease. The recommendations are based on research conducted by Oskar Hansson, one of MultiPark’s research group leaders.

“Blood-based biomarkers for Alzheimer’s are already improving the design of clinical trials, and they are very likely to revolutionize the diagnosis of Alzheimer’s in the future,” says Oskar Hansson in Alzheimer’s associations press release.

Read the full press release here.